Consensus recommendations for the diagnosis and treatment of acquired hemophilia A
2010 · BMC Research Notes · 188 citations
https://doi.org/10.1186/1756-0500-3-161
M
María Eva Mingot‐Castellano
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
173
Papers
2.2K
Citations
25
h-index
53
i10-index
María Eva Mingot‐Castellano is an academic researcher from Instituto de Biomedicina de Sevilla. The author has contributed to research in topics: Platelet Disorders and Treatments & Hemophilia Treatment and Research & Blood groups and transfusion. The author has an h-index of 25, co-authored 148 publications.
ORCID: 0000-0001-9083-855XPapers by this author
worksEvans syndrome in adults: an observational multicenter study
2021 · Blood Advances · 68 citations
https://doi.org/10.1182/bloodadvances.2021005610
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia
2019 · Scientific Reports · 23 citations
https://doi.org/10.1038/s41598-019-53209-y
Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience
2022 · Blood · 8 citations
https://doi.org/10.1182/blood.2022016818
Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia
2021 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-021-95732-x
HTA335 A Multi-Criteria Decision Analysis (MCDA) to Determine the Value of Recombinant ADAMTS3 Vs Standard of Care in Congenital Thrombotic Thrombocytopenic Purpura (cTTP) in Spain
2024 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2024.10.2160
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat